5.03
-0.02(-0.40%)
Currency In USD
| Previous Close | 5.05 |
| Open | 5.02 |
| Day High | 5.06 |
| Day Low | 4.91 |
| 52-Week High | 6.78 |
| 52-Week Low | 3.21 |
| Volume | 2.51M |
| Average Volume | 3.64M |
| Market Cap | 1.21B |
| PE | -20.96 |
| EPS | -0.24 |
| Moving Average 50 Days | 5.87 |
| Moving Average 200 Days | 4.99 |
| Change | -0.02 |
If you invested $1000 in Ardelyx, Inc. (ARDX) 10 years ago, it would be worth $1,043.57 as of October 19, 2025 at a share price of $5.03. Whereas If you bought $1000 worth of Ardelyx, Inc. (ARDX) shares 5 years ago, it would be worth $3,671.53 as of October 19, 2025 at a share price of $5.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
GlobeNewswire Inc.
Oct 13, 2025 12:35 PM GMT
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
GlobeNewswire Inc.
Oct 13, 2025 12:30 PM GMT
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs
Ardelyx Announces Changes to the Executive Leadership Team
GlobeNewswire Inc.
Aug 04, 2025 8:08 PM GMT
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSW